NR3C1 and breast cancer: Subgroup analysis of oestrogen negative (ER-) breast cancer shows that high GR expression reduced PFS in early untreated cancers (HR 1.73, 95% CI (1.35, 2.23)) with low heterogeneity using a random effects model (I2 < 0.01%; p = 0.631) (Figure 5).